(Q54975278)

14 June 2018

title

Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride. (English)

1 reference

14 June 2018

author name string

K Hori

1

1 reference

14 June 2018

S Saito

2

1 reference

14 June 2018

H Takahashi

3

1 reference

14 June 2018

H Sato

4

1 reference

14 June 2018

H Maeda

5

1 reference

14 June 2018

Y Sato

6

1 reference

14 June 2018

publication date

1 February 2000

1 reference

14 June 2018

number of pages

9

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

14 June 2018

volume

91

1 reference

14 June 2018

issue

2

1 reference

14 June 2018

page(s)

261-269

1 reference

14 June 2018

SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Endothelin Receptors and Angiotensin II Receptors in Tumor Tissue

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Effect of sodium nitroprusside-induced hypotension on the blood flow in subcutaneous and intramuscular BT4AN tumors and normal tissues in rats

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Functional characterization of the microcirculation in tumors

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Increased intratumor concentration of fluorescein-isothiocyanate-labeled neocarzinostatin in rats under angiotensin-induced hypertension

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

In vivo targets of recombinant human tumour necrosis factor-alpha: blood flow, oxygen consumption and growth of isotransplanted rat tumours

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Blood flow modification in the sccvii tumor: Effects of 5-Hydroxytryptamine, hydralazine, and propanolol

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Vinca alkaloids: anti-vascular effects in a murine tumour

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

In vivo analysis of tumor vascularization in the rat.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926331

Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers

13 August 2018

1 reference

12 December 2020

A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II

1 reference

12 December 2020

Changes of Oxygen Tension in Tumours Induced by Vasoconstrictor and Vasodilator Drugs

1 reference

12 December 2020

Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer

1 reference

12 December 2020

Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action

1 reference

12 December 2020

Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid

1 reference

12 December 2020

The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain

1 reference

12 December 2020

Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow

1 reference

12 December 2020

MEASUREMENT OF LOCAL BLOOD FLOW WITH HYDROGEN GAS

1 reference

12 December 2020

Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid

1 reference

12 December 2020

Angiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging

1 reference

12 December 2020

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

1 reference

12 December 2020

Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumour

1 reference

12 December 2020

Vascular reactions of normal and malignant tissues in Vivo. VI. The role of hypotension in the action of components of podophyllin on transplanted sarcomas

1 reference

12 December 2020

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism

1 reference

12 December 2020

Angiotensin II receptors in cortical and medullary adrenal tumors

1 reference

12 December 2020

10.1111/J.1349-7006.2000.TB00940.X

Identifiers

DOI

1 reference

14 June 2018

PMC publication ID

5926331

1 reference

14 June 2018

PubMed publication ID

10761715

1 reference

14 June 2018